Genvira specializes in viral engineering. We design, construct and characterize customized DNA and RNA viruses for cancer immunotherapy, gene therapy, vaccines. In addition, Genvira conducts viral and non-viral based cell engineering. Our contract research services include, end-to-end engineering, consulting for CMC and regulatory filing and pre-clinical animal models and efficacy study. Our small scale production suite can manufacture sufficient materials for pre-clinical studies.